METHOD FOR TREATMENT AND PREVENTION OF RESPIRATORY INSUFFICIENCY

(19)

(11)

EP 1 893 039 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	18.07.2012 Bulletin 2012/29

(45)	Mention of the grant of the patent:
	30.05.2012 Bulletin 2012/22

(21)	Application number: 06724215.6

(22)	Date of filing: 11.04.2006

(51)

International Patent Classification (IPC):

A23L 1/30^(2006.01)
A61K 31/202^(2006.01)

A23L 1/29^(2006.01)

(86)	International application number:
	PCT/EP2006/003285

(87)	International publication number:
	WO 2006/111295 (26.10.2006 Gazette 2006/43)

(54)	METHOD FOR TREATMENT AND PREVENTION OF RESPIRATORY INSUFFICIENCY VERFAHREN ZUR BEHANDLUNG UND VERHINDERUNG VON RESPIRATORISCHER INSUFFIZIENZ TRAITEMENT ET PREVENTION DE L'INSUFFISANCE RESPIRATOIRE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

21.04.2005 EP 05008771

(43)	Date of publication of application:
	05.03.2008 Bulletin 2008/10

(73)	Proprietors:
	Beermann, Christopher 36100 Petersberg (DE) Zielen, Stefan 65719 Hofheim (DE) Boehles, Hans Josef 60322 Frankfurt/Main (DE) Schubert, Ralf 64367 Mühltal (DE)

(72)	Inventors:
	Beermann, Christopher 36100 Petersberg (DE) Zielen, Stefan 65719 Hofheim (DE) Boehles, Hans Josef 60322 Frankfurt/Main (DE) Schubert, Ralf 64367 Mühltal (DE)

(74)	Representative: Köster, Hajo
	propindus Patentanwälte Niedmers Jaeger Köster Pippinplatz 4a 82131 Gauting 82131 Gauting (DE)

(56)

References cited: :

EP-A- 0 457 950
WO-A-93/19624

EP-A- 0 711 503

MANCUSO P ET AL: "EFFECTS OF EICOSAPENTAENOIC AND GAMMA-LINOLENIC ACID ON LUNG PERMEABILITY AND ALVEOLAR MACROPHAGE EICOSANOID SYNTHESIS IN ENDOTOXIC RATS" CRITICAL CARE MEDICINE, WILLIAMS AND WILKINGS COMPANY, BALTIMORE, MA, US, vol. 25, no. 3, March 1997 (1997-03), pages 523-532, XP008044589 ISSN: 0090-3493
PALOMBO J D ET AL: "Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats." CRITICAL CARE MEDICINE. SEP 1999, vol. 27, no. 9, September 1999 (1999-09), pages 1908-1915, XP008053257 ISSN: 0090-3493
GADEK J E ET AL: "Effect of enteral feeding with eicosapentaenoic acid, [gamma]-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome" CRITICAL CARE MEDICINE 1999 UNITED STATES, vol. 27, no. 8, 1999, pages 1409-1420, XP008053256 ISSN: 0090-3493
PEAT JENNIFER K ET AL: "Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study." THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. OCT 2004, vol. 114, no. 4, October 2004 (2004-10), pages 807-813, XP002348290 ISSN: 0091-6749
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 01, 30 January 1998 (1998-01-30) & JP 09 234019 A (NOF CORP), 9 September 1997 (1997-09-09)

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).